Skip to content
Search

Latest Stories

AIMp rebrands as IPA to amplify the voice of independent pharmacies

AIMp rebrands as IPA to amplify the voice of independent pharmacies

David Vanns, currently serving as the chairman of AIMp, will retain his position as chairman of Independent Pharmacies Association (IPA) 

The Association of Independent Multiple Pharmacies (AIMp) has changed its name to the Independent Pharmacies Association (IPA).

AIMp, now IPA, stated that rebranding was prompted by the demand from independent community pharmacists for an association that properly represents their interests.


The membership of the Independent Pharmacies Association will not be restricted to pharmacy owners with multiple branches, as was the case with AIMp, but will be open to all independents, it announced today (Tuesday).

It believes that the switch will “provide a clearer identity and afford a strong voice to the thousands of independent pharmacies in England and Wales.”

Furthermore, the IPA noted that it will not primarily function as an insurance organisation with membership attached, but it will be “fighting for and representing its members across all fronts.”

David Vanns, currently serving as the chairman of AIMp, will retain his position as chairman of IPA.

Vanns said: “Our businesses are set up very differently to others in the sector. For independent brick and mortar contractors, supplying NHS prescriptions, and services and treatments via the new NHS Pharmacy First scheme, is their priority.

“IPA is truly run by pharmacy contractors for pharmacy contractors. We understand community pharmacy. Our growing membership is a testament to our organisation’s dedication to speak up with courage and conviction on behalf of independent community pharmacies and offer them the support they need.”

The association highlighted that independent pharmacies, many of which are family owned, constitute roughly 68 per cent of the sector in England, and large chains make up about 29 per cent. However, the latter are “over-represented on the board of Community Pharmacy England, the body that negotiates contracts with the Government and NHS.”

“Independent community pharmacies do not operate the same business models as the large chains (Boots, supermarkets, Superdrug etc). They are not health and beauty, sandwiches and snacks-on-the-go retailers first, supplying medicines and prescriptions second. They are not corporates. Over 90 per cent of the independent’s business derives directly from the NHS,” the IPA said.

Despite the crucial frontline healthcare they provide, independent pharmacies in the country “struggle to make themselves heard and their needs are often overlooked,” the IPA stated adding that its strategy is to “ensure our members can thrive and are fully supported and represented.”

Vanns added: “We will press the cause of all independents and ensure they are properly represented on CPE and to the external stakeholders and decision-makers.

“We are here for our customers, our patients, and we’re always happy to work closely with the NHS to relieve pressure in other areas, but it is only right that we are treated with respect and that we are paid accordingly. From now on, the IPA will be making certain that is the case.”

'We need unity and not split the voice'

Commenting on AIMp's transition into IPA, Paul Rees, CEO of the National Pharmacy Association (NPA) said: “At a time when pharmacies are under such intense pressure, they need us to focus on the fight against the broken contract and unfair funding, which is damaging so many."

“We need unity in the sector and not split the voice of independent pharmacies when we need to concentrate on winning better funding and ending the closures. That’s our focus at the NPA."

Expanding on the NPA's priorities, he said: “As the largest membership body for community pharmacies, we’re proud to support the majority of independents across the UK. Our focus is entirely on making a powerful case for pharmacies, in public, with government and opposition and with the NHS.

“We will work with all our colleagues within our sector – anytime, anywhere – in the interests of unity to end pharmacy closures and end the misery of unfair and inadequate funding.”

More For You

Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less